SEC Comment Letter 0000000000-25-002524 to Golden Sun Technology Group Ltd. (GSUN)
Golden Sun Technology Group Ltd.
Date: March 6, 2025 · CIK: 0001826376 · Accession: 0000000000-25-002524
AI Filing Summary & Sentiment
Letter
March 6, 2025 Xueyuan Weng Chief Executive Officer Golden Sun Health Technology Group Ltd Room 503, Building C2, No. 1599 Xinjinqiao Road, Pudong New Area Shanghai, China 200083 Re:Golden Sun Health Technology Group Ltd Draft Registration Statement on Form F-1 Submitted February 26, 2025 CIK No. 0001826376 Dear Xueyuan Weng: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Kate Beukenkamp at 202-551-3861 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc:Charles Yongjun Fu
Show Raw Text
March 6, 2025
Xueyuan Weng
Chief Executive Officer
Golden Sun Health Technology Group Ltd
Room 503, Building C2, No. 1599
Xinjinqiao Road, Pudong New Area
Shanghai, China 200083
Re:Golden Sun Health Technology Group Ltd
Draft Registration Statement on Form F-1
Submitted February 26, 2025
CIK No. 0001826376
Dear Xueyuan Weng:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement no later than 48 hours
prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding
requests for acceleration. We remind you that the company and its management are
responsible for the accuracy and adequacy of their disclosures, notwithstanding any review,
comments, action or absence of action by the staff.
Please contact Kate Beukenkamp at 202-551-3861 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:Charles Yongjun Fu